Potential pinch leading to reversal possibilities. I've mentioned the S1 support zone which was a bit more than tested today. Is this just a technical bounce or the leading edge of a reversal? For reversal we'll need confirmation. Divergence starting to move in the right direction though needs to cross positive. Just looking at the daily, not the intraday charts. Pivot is 1.04 with the 20dma resistance at 1.022 if crossed would be support.

mumbo jumbo to many of you, but let's see confirmation come through for us leading into results and get some momentum going.


[chart]stockcharts.com/c-sc/sc?s=CTIX&p=D&yr=0&mn=1&dy=0&i=t48635263521&r=1488230117957[/chart]

Quote:

---

Message in reply to:

We know what's happening and the fundamentals are just getting more solid.
A quick glance without ANY indicators, or knowing anything about Cellceutix, just by going by the chart, not so sure I'd be looking to take a position.

And for that reason, I'm posting a BUY recommendation.

It really isn't until you zoom out to the multi year chart that this looks interesting. Sad for many really that manipulation and a little funding has taken its toll over the last couple years. Kudos to management for exceeding expectations on science AND really keeping dilution VERY minimal. Cash on hand and enough financing to carry current trials to the end. The design of these trials actually only begin to exploit the potential. That's where it starts to get exciting. Kevetrin for ovarian cancer and further potential beyond for many indications. Brilacidin for colitis, not at all a small market there. Prurisol, with the best to date reducing side effects and providing complete help to those suffering.
Worth the look into the pipeline.
Technically, and I do work more from the charts myself, .87 is the main support. Already looking to add more if I can free up more cash.

---